Global Vaccine Adjuvants Market Research Report 2024(Status and Outlook)

Global Vaccine Adjuvants Market Research Report 2024(Status and Outlook)



Report Overview:

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The Global Vaccine Adjuvants Market Size was estimated at USD 938.05 million in 2023 and is projected to reach USD 1573.20 million by 2029, exhibiting a CAGR of 9.00% during the forecast period.

This report provides a deep insight into the global Vaccine Adjuvants market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine Adjuvants Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine Adjuvants market in any manner.

Global Vaccine Adjuvants Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Brenntag Biosector

MVP Laboratories

Zhuoyue

Aphios

Market Segmentation (by Type)

Aluminum Adjuvant

Emulsions Adjuvant

Others

Market Segmentation (by Application)

Human Vaccine

Veterinary Vaccine

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Vaccine Adjuvants Market
  • Overview of the regional outlook of the Vaccine Adjuvants Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine Adjuvants Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vaccine Adjuvants
1.2 Key Market Segments
1.2.1 Vaccine Adjuvants Segment by Type
1.2.2 Vaccine Adjuvants Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vaccine Adjuvants Market Overview
2.1 Global Market Overview
2.1.1 Global Vaccine Adjuvants Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vaccine Adjuvants Market Competitive Landscape
3.1 Global Vaccine Adjuvants Sales by Manufacturers (2019-2024)
3.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine Adjuvants Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine Adjuvants Sales Sites, Area Served, Product Type
3.6 Vaccine Adjuvants Market Competitive Situation and Trends
3.6.1 Vaccine Adjuvants Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine Adjuvants Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Vaccine Adjuvants Industry Chain Analysis
4.1 Vaccine Adjuvants Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Vaccine Adjuvants Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Vaccine Adjuvants Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine Adjuvants Sales Market Share by Type (2019-2024)
6.3 Global Vaccine Adjuvants Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine Adjuvants Price by Type (2019-2024)
7 Vaccine Adjuvants Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine Adjuvants Market Sales by Application (2019-2024)
7.3 Global Vaccine Adjuvants Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine Adjuvants Sales Growth Rate by Application (2019-2024)
8 Vaccine Adjuvants Market Segmentation by Region
8.1 Global Vaccine Adjuvants Sales by Region
8.1.1 Global Vaccine Adjuvants Sales by Region
8.1.2 Global Vaccine Adjuvants Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine Adjuvants Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine Adjuvants Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine Adjuvants Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine Adjuvants Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine Adjuvants Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 GSK
9.1.1 GSK Vaccine Adjuvants Basic Information
9.1.2 GSK Vaccine Adjuvants Product Overview
9.1.3 GSK Vaccine Adjuvants Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Vaccine Adjuvants SWOT Analysis
9.1.6 GSK Recent Developments
9.2 CSL Limited
9.2.1 CSL Limited Vaccine Adjuvants Basic Information
9.2.2 CSL Limited Vaccine Adjuvants Product Overview
9.2.3 CSL Limited Vaccine Adjuvants Product Market Performance
9.2.4 CSL Limited Business Overview
9.2.5 CSL Limited Vaccine Adjuvants SWOT Analysis
9.2.6 CSL Limited Recent Developments
9.3 Croda
9.3.1 Croda Vaccine Adjuvants Basic Information
9.3.2 Croda Vaccine Adjuvants Product Overview
9.3.3 Croda Vaccine Adjuvants Product Market Performance
9.3.4 Croda Vaccine Adjuvants SWOT Analysis
9.3.5 Croda Business Overview
9.3.6 Croda Recent Developments
9.4 SEPPIC
9.4.1 SEPPIC Vaccine Adjuvants Basic Information
9.4.2 SEPPIC Vaccine Adjuvants Product Overview
9.4.3 SEPPIC Vaccine Adjuvants Product Market Performance
9.4.4 SEPPIC Business Overview
9.4.5 SEPPIC Recent Developments
9.5 Novavax
9.5.1 Novavax Vaccine Adjuvants Basic Information
9.5.2 Novavax Vaccine Adjuvants Product Overview
9.5.3 Novavax Vaccine Adjuvants Product Market Performance
9.5.4 Novavax Business Overview
9.5.5 Novavax Recent Developments
9.6 SPI Pharma
9.6.1 SPI Pharma Vaccine Adjuvants Basic Information
9.6.2 SPI Pharma Vaccine Adjuvants Product Overview
9.6.3 SPI Pharma Vaccine Adjuvants Product Market Performance
9.6.4 SPI Pharma Business Overview
9.6.5 SPI Pharma Recent Developments
9.7 Phibro
9.7.1 Phibro Vaccine Adjuvants Basic Information
9.7.2 Phibro Vaccine Adjuvants Product Overview
9.7.3 Phibro Vaccine Adjuvants Product Market Performance
9.7.4 Phibro Business Overview
9.7.5 Phibro Recent Developments
9.8 SDA BIO
9.8.1 SDA BIO Vaccine Adjuvants Basic Information
9.8.2 SDA BIO Vaccine Adjuvants Product Overview
9.8.3 SDA BIO Vaccine Adjuvants Product Market Performance
9.8.4 SDA BIO Business Overview
9.8.5 SDA BIO Recent Developments
9.9 Invivogen
9.9.1 Invivogen Vaccine Adjuvants Basic Information
9.9.2 Invivogen Vaccine Adjuvants Product Overview
9.9.3 Invivogen Vaccine Adjuvants Product Market Performance
9.9.4 Invivogen Business Overview
9.9.5 Invivogen Recent Developments
9.10 Tj Kaiwei
9.10.1 Tj Kaiwei Vaccine Adjuvants Basic Information
9.10.2 Tj Kaiwei Vaccine Adjuvants Product Overview
9.10.3 Tj Kaiwei Vaccine Adjuvants Product Market Performance
9.10.4 Tj Kaiwei Business Overview
9.10.5 Tj Kaiwei Recent Developments
9.11 OZ Biosciences
9.11.1 OZ Biosciences Vaccine Adjuvants Basic Information
9.11.2 OZ Biosciences Vaccine Adjuvants Product Overview
9.11.3 OZ Biosciences Vaccine Adjuvants Product Market Performance
9.11.4 OZ Biosciences Business Overview
9.11.5 OZ Biosciences Recent Developments
9.12 Brenntag Biosector
9.12.1 Brenntag Biosector Vaccine Adjuvants Basic Information
9.12.2 Brenntag Biosector Vaccine Adjuvants Product Overview
9.12.3 Brenntag Biosector Vaccine Adjuvants Product Market Performance
9.12.4 Brenntag Biosector Business Overview
9.12.5 Brenntag Biosector Recent Developments
9.13 MVP Laboratories
9.13.1 MVP Laboratories Vaccine Adjuvants Basic Information
9.13.2 MVP Laboratories Vaccine Adjuvants Product Overview
9.13.3 MVP Laboratories Vaccine Adjuvants Product Market Performance
9.13.4 MVP Laboratories Business Overview
9.13.5 MVP Laboratories Recent Developments
9.14 Zhuoyue
9.14.1 Zhuoyue Vaccine Adjuvants Basic Information
9.14.2 Zhuoyue Vaccine Adjuvants Product Overview
9.14.3 Zhuoyue Vaccine Adjuvants Product Market Performance
9.14.4 Zhuoyue Business Overview
9.14.5 Zhuoyue Recent Developments
9.15 Aphios
9.15.1 Aphios Vaccine Adjuvants Basic Information
9.15.2 Aphios Vaccine Adjuvants Product Overview
9.15.3 Aphios Vaccine Adjuvants Product Market Performance
9.15.4 Aphios Business Overview
9.15.5 Aphios Recent Developments
10 Vaccine Adjuvants Market Forecast by Region
10.1 Global Vaccine Adjuvants Market Size Forecast
10.2 Global Vaccine Adjuvants Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaccine Adjuvants Market Size Forecast by Country
10.2.3 Asia Pacific Vaccine Adjuvants Market Size Forecast by Region
10.2.4 South America Vaccine Adjuvants Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaccine Adjuvants by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Vaccine Adjuvants Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaccine Adjuvants by Type (2025-2030)
11.1.2 Global Vaccine Adjuvants Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaccine Adjuvants by Type (2025-2030)
11.2 Global Vaccine Adjuvants Market Forecast by Application (2025-2030)
11.2.1 Global Vaccine Adjuvants Sales (Kilotons) Forecast by Application
11.2.2 Global Vaccine Adjuvants Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings